166 related articles for article (PubMed ID: 9792470)
1. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
Grauer A; Raue F; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
[TBL] [Abstract][Full Text] [Related]
2. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
3. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of an immunoassay for calcitonin].
Sylla Niang M; Lombardo F; Schlumberger M; Bidart JM
Dakar Med; 2008; 53(1):76-83. PubMed ID: 19102121
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
9. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
10. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
11. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease.
Saller B; Görges R; Reinhardt W; Haupt K; Janssen OE; Mann K
Clin Lab; 2002; 48(3-4):191-200. PubMed ID: 11934221
[TBL] [Abstract][Full Text] [Related]
12. [Can measurement of basal calcitonin replace the pentagastrin test?].
Vestergaard P; Jönsson AL; Christiansen P; Frohnert J
Ugeskr Laeger; 2008 Oct; 170(41):3238-42. PubMed ID: 18940156
[TBL] [Abstract][Full Text] [Related]
13. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
[TBL] [Abstract][Full Text] [Related]
14. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
15. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
16. Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay.
Verga U; Morpurgo PS; Vaghi I; Radetti G; Beck-Peccoz P
Horm Res; 2006; 66(1):17-20. PubMed ID: 16636574
[TBL] [Abstract][Full Text] [Related]
17. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
18. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
[TBL] [Abstract][Full Text] [Related]
19. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis.
Schuetz M; Beheshti M; Oezer S; Novotny C; Paul M; Hofmann A; Bieglmayer C; Niederle B; Kletter K; Dudczak R; Karanikas G; Pirich C
Anticancer Res; 2006; 26(1B):723-7. PubMed ID: 16739344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
